share_log

UnitedHealth | 10-Q: Quarterly report

SEC announcement ·  May 9 16:46
Summary by Moomoo AI
UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $99.8 billion for the first quarter of 2024, compared to the same period in 2023. The growth was primarily driven by an increase in the number of people served through Medicare Advantage and domestic commercial offerings, as well as pricing trends and growth in Optum Health and Optum Rx. However, the company recorded a net loss of $1.4 billion, attributed to a $7.1 billion loss from the sale of its Brazil operations and the impact of a cyberattack on Change Healthcare. The cyberattack resulted in $593 million of direct response costs and an estimated $279 million in business disruption impacts for the quarter. UnitedHealthcare revenues grew by 7%, while Optum revenues saw a 13% increase. Despite these challenges, UnitedHealthcare...Show More
UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $99.8 billion for the first quarter of 2024, compared to the same period in 2023. The growth was primarily driven by an increase in the number of people served through Medicare Advantage and domestic commercial offerings, as well as pricing trends and growth in Optum Health and Optum Rx. However, the company recorded a net loss of $1.4 billion, attributed to a $7.1 billion loss from the sale of its Brazil operations and the impact of a cyberattack on Change Healthcare. The cyberattack resulted in $593 million of direct response costs and an estimated $279 million in business disruption impacts for the quarter. UnitedHealthcare revenues grew by 7%, while Optum revenues saw a 13% increase. Despite these challenges, UnitedHealthcare served 1.6 million more people domestically, primarily in commercial and Medicare offerings. The company's operating margin decreased slightly from 8.8% to 7.9%, and the medical care ratio increased by 2.1%. Looking ahead, UnitedHealth Group anticipates continued growth in health care spending and is focusing on managing operating costs and medical cost trends, including the resumption of care management activities suspended due to the cyberattack.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more